Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Tetraphase Pharmaceuticals Inc (NASDAQ:TTPH)

8.10
Delayed Data
As of Apr 24
 +0.01 / +0.12%
Today’s Change
3.11
Today|||52-Week Range
9.93
+100.99%
Year-to-Date

Today’s Trading

Previous close8.09
Today’s open8.17
Day’s range7.85 - 8.24
Volume277,232
Average volume (3 months)526,361
Market cap$299.8M
Dividend yield--
Data as of 04/24/2017

Growth & Valuation

Earnings growth (last year)+10.59%
Earnings growth (this year)--
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-55.97%
P/E ratioNM
Price/Sales28.75
Price/Book2.13

Competitors

 Today’s
change
Today’s
% change
NBRVNabriva Therapeutics...-0.14-1.28%
COLLCollegium Pharmaceut...-0.11-1.07%
ZYNEZynerba Pharmaceutic...-0.48-2.07%
SVASinovac Biotech Ltd+0.01+0.18%
Data as of 04/24/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.55
Annual revenue (last year)$5.1M
Annual profit (last year)-$77.5M
Net profit margin-1,505.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Guy MacDonald
Principal Financial &
Accounting Officer
Christopher Watt
Corporate headquarters
Watertown, Massachusetts

Forecasts


Search for Jobs